Evidence map›Paper›PMID 18852695›Full record

ReviewNature reviews. Genetics2008

Metabolic syndrome: from epidemiology to systems biology.

Aldons J Lusis, Alan D Attie, Karen Reue

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 171 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
171citing papers in PubMed, 3 pooled it
15.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01616563 nacompletednot on this mapstarted 2012, after this paper: background citation

Canadian Health Advanced By Nutrition and Graded Exercise: CHANGE Health Paradigm

TypeinterventionalSponsorDaren K. HeylandRan2012 to 2016Enrolled305ConditionsMetabolic SyndromeArmsDietary Intervention, Exercise Prescription and Fitness Program
NCT01753245 unknown statusnot on this mapstarted 2012, after this paper: background citation

Cardiovascular risk factors in a spanish population of patients with moderate-to-severe psoriasis vulgaris, with or without arthritis, treated with anti-tnf in real clinical practice. analysis of the influence of metabolic syndrome on treatment efficacy.

TypeobservationalSponsorJuan RuanoRan2012 to 2014Enrolled300ConditionsPsoriasis Vulgaris, Metabolic Syndrome
3 · Its place in the literature

Who cites it

171 citing papers in PubMed, 3 syntheses or guidelines pooled it, 352 citations in OpenAlex.

  1. Metabolic Syndrome and Obesity-related cancer Risk and Survival: An Umbrella Review of Systematic Reviews With Meta-analysis of Observational Studies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Pooled it
  2. Pooled it
  3. Pleiotropic genes for metabolic syndrome and inflammation.Molecular genetics and metabolism · 2014
    Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Microfluidics-Based Microcarriers for Live-Cell Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Modulatory Roles ofViruses · 2024
    Article
  20. Article

111 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Aldons J LusisDepartment of Medicine and Department of Microbiology, Immunology and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, California 90095, USA. jlusis@mednet.ucla.edu
Alan D Attie
Karen Reue
University of California, Los Angeles · USUniversity of Wisconsin–Madison · US

Funding

ULTRASTRUCTURE OF THE INTIMA IN EARLY LESION FORMATIONP01HL030568 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGELMAN, ALAN M · 1985 to 2019
$55.2M
Systems genomics of metabolic syndrome traitsP01HL028481 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REUE, KAREN · 1985 to 2019
$50.2M
NHLBI NIH HHS P01 HL028481NHLBI NIH HHS P01 HL030568
6 · The paper itself

Abstract

Metabolic syndrome (MetSyn) is a group of metabolic conditions that occur together and promote the development of cardiovascular disease (CVD) and diabetes. Recent genome-wide association studies have identified several novel susceptibility genes for MetSyn traits, and studies in rodent models have provided important molecular insights. However, as yet, only a small fraction of the genetic component is known. Systems-based approaches that integrate genomic, molecular and physiological data are complementing traditional genetic and biochemical approaches to more fully address the complexity of MetSyn.

Indexed as

Genetic VariationEpigenesis, GeneticGenetic Predisposition to DiseaseGenomicsHumansInsulin ResistanceMetabolic SyndromeRisk FactorsSex FactorsSystems Biology

Identifiers

PMID18852695
PMCPMC2829312
OpenAlexW2062860983

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.